Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2019-09-05 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the seventh meeting of the fourth board of directors of the company 福安药业（集团）股份有限公司. It includes details about the meeting date, attendance, and voting results on a specific agenda item related to a share transfer and capital increase agreement. The document does not contain financial statements or detailed financial analysis, nor is it a full report. It is an announcement of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2019-09-05 Chinese
关于签订《股权购买和增资协议》的公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement about the signing of a "Share Purchase and Capital Increase Agreement" involving the acquisition of 51% equity in Red Realty LLC by the company 福安药业（集团）股份有限公司. It includes transaction overview, parties involved, financial data, valuation, terms of the agreement, guarantees, risk disclosures, and legal considerations. The content focuses on a capital investment and acquisition transaction, including share transfer, capital increase, and related contractual terms. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a simple announcement of voting results or a regulatory filing. The document is a comprehensive capital/financing update related to a significant equity acquisition and capital increase. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-09-05 Chinese
独立董事关于第四届董事会第七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters related to the company's board meeting, specifically regarding a share transfer and capital increase agreement. It references regulatory guidelines for independent directors and company governance but does not contain financial statements or detailed financial data. The document is a formal opinion related to board/management decisions rather than a full report or announcement of financial results. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on governance matters, not a full report or announcement.
2019-09-05 Chinese
拟核实企业价值所涉及的RED REALTY LLC股东全部权益价值资产估值报告
Audit Report / Information Classification · 95% confidence The document is an asset valuation report for RED REALTY LLC commissioned by 福安药业（集团）股份有限公司. It includes detailed valuation methods, assumptions, financial data, and an audit report reference. The document is lengthy (15,000 characters) and contains substantive financial and valuation analysis, not merely an announcement or summary. It is not an annual or interim financial report, nor a regulatory filing or certification. It is a standalone asset valuation report, which fits the category of Audit Report / Information (AR) as it includes valuation results, applied methods, and audit references but is not a full annual report or earnings release. Therefore, the appropriate classification is AR with high confidence. Q2 2019
2019-09-05 Chinese
RED REALTY LLC自2019年3月27日（公司设立日）至2019年7月31日期间审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report for RED REALTY LLC covering the period from the company's establishment on March 27, 2019, to July 31, 2019. It includes an auditor's opinion, detailed financial statements (balance sheet, income statement, cash flow statement, statement of changes in equity), and extensive notes on accounting policies and financial details. The presence of an auditor's opinion and detailed financial statements indicates this is a standalone audit report rather than a full annual report or interim report. The document is about 15,000 characters long, which is substantial and contains the full audit report and financial statements, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2019
2019-09-05 Chinese
第四届监事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company 福安药业 regarding the approval of a proposal related to a share transfer and capital increase agreement. It is a formal meeting resolution announcement, not a full report or financial statement. The document is short (511 characters) and does not contain financial data or detailed report content. It is an official announcement of a board meeting decision, which fits best under the category of Board/Management Information (MANG).
2019-09-05 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.